Snus is banned everywhere in the EU except Sweden because Sweden negotiated an exemption as a condition of joining in 1995, and the EU has refused to extend it since. The prohibition is one sentence of Article 17 of Directive 2014/40/EU. Sweden is not merely permitted to sell snus — it is legally obliged to stop it reaching other member states.
The question gets asked as though there were a scientific answer hiding behind it: what is it about snus that Brussels knows and Stockholm does not? There isn’t one. The answer is almost entirely procedural, and the procedure is a good deal stranger than the science.
What follows is the paper trail: the directive, the accession treaty, three judgments of the Court of Justice, and the definitional gap that nicotine pouches now sit in. I have quoted the operative wording rather than paraphrasing it, because in this subject the paraphrases have drifted a long way from the texts.
The ban itself is one sentence long
Article 17 of Directive 2014/40/EU — the Tobacco Products Directive, adopted 3 April 2014 — reads, in full:
“Member States shall prohibit the placing on the market of tobacco for oral use, without prejudice to Article 151 of the Act of Accession of Austria, Finland and Sweden.”
That is the entire article. Twenty-six words, and roughly half of them are the Swedish carve-out. Article 1(c) lists among the directive’s objectives “the prohibition on the placing on the market of tobacco for oral use”, and that is the whole of the EU’s engagement with the subject at the operative level.
What gets banned is defined at Article 2(8):
“‘tobacco for oral use’ means all tobacco products for oral use, except those intended to be inhaled or chewed, made wholly or partly of tobacco, in powder or in particulate form or in any combination of those forms, particularly those presented in sachet portions or porous sachets;”
Two things in that definition do a great deal of work. The first is “except those intended to be inhaled or chewed”. American chewing tobacco is legal across the EU; Swedish snus is not, and the difference is a stated intention about how the product is used rather than anything about what is in it. The second is “made wholly or partly of tobacco”, which is the hinge the entire nicotine pouch category now hangs from — more on that below.
Why 1992, and why the reasoning has aged oddly
The ban is older than the current directive. It arrived with Council Directive 92/41/EEC of 15 May 1992, which inserted a new Article 8a into the 1989 labelling directive: “Member States shall prohibit the placing on the market of tobacco for oral use as defined in Article 2 (4).”
The recitals set out why. They are worth reading in the original, because the stated reason is not the one most people assume:
“Whereas, moreover, new tobacco products for oral use which have appeared on the market in certain Member States are particularly attractive to young people and whereas the Member States most exposed to this problem have already placed total bans on these new tobacco products or intend so to do;”
“Whereas there is a real risk that the new products for oral use will be used above all by young people, thus leading to nicotine addiction, unless restrictive measures are taken in time;”
The 1992 case is about novelty and youth uptake. It is not a comparative-harm finding against cigarettes, and it does not claim snus is worse than smoking. I went looking for an EU document that does make that comparison and could not find one. Across 1992, 2001 and 2014 the stated justification is consistently the same three things: a product new to those markets, attractive to young people, addictive and with adverse health effects in absolute terms. Recital 32 of the current directive puts it plainly — the prohibition “should be maintained in order to prevent the introduction in the Union (apart from Sweden) of a product that is addictive and has adverse health effects.”
Note also a small drafting change that nobody mentions. The 1992 definition excluded products “intended to be smoked or chewed”. The 2014 definition excludes those “intended to be inhaled or chewed”. Same structure, different first verb.
Sweden’s exemption is an accession bargain, and it comes with a duty attached
Sweden joined the European Union on 1 January 1995, three years after the ban. The exemption sits in the 1994 Act of Accession, and the Court of Justice set out its terms in Case C-210/03 at paragraph 11. Point (a):
“The prohibition in Article 8a of Directive 89/622/EEC, as amended …, concerning the placing on the market of the product defined in Article 2(4) of [the] Directive … shall not apply [in the Kingdom of Sweden …], with the exception of the prohibition to place this product on the market in a form resembling a food product.”
And then point (b), which is the half of the bargain that almost never gets quoted:
“[The Kingdom of Sweden] shall take all measures necessary to ensure that the product referred to in paragraph (a) is not placed on the market in the Member States for which Directives 89/622/EEC and 92/41/EEC are fully applicable.”
Read those together and the shape of the thing changes. Sweden is not simply left alone to do as it likes. It is exempted on its own territory and simultaneously placed under a positive obligation to keep snus out of everyone else’s market. That is why a Swedish retailer will ship snus to Norway or the United States but not to Germany, and why the barrier is not merely the German import rule but a duty binding on Sweden itself. The two limbs are one deal.
Recital 32 of the 2014 directive confirms the hook: “Article 151 of the Act of Accession of Austria, Finland and Sweden grants Sweden a derogation from the prohibition.” Recital 20 adds a consequence that reads oddly in an internal-market instrument — responsibility for regulating the ingredients of oral tobacco “should, in accordance with the principle of subsidiarity, remain with Sweden, where the sale of this product is permitted”. The EU bans the product everywhere else and hands its ingredient rules to the one country that sells it.
The courts have been asked three times, and said no three times
The ban has survived every challenge. The judgments are where the asymmetry gets its legal justification, and the reasoning repays attention.
On 14 December 2004 the Court decided Arnold André (C-434/02) and Swedish Match (C-210/03) on the same day. In the second, the question of whether exempting one member state breached equal treatment was put squarely, and the answer turned on a piece of reasoning that is either elegant or circular depending on your mood. At paragraph 67:
“Since Article 151 of the Act of Accession precisely excluded the Kingdom of Sweden from the scope of the prohibition adopted in 1992, the territory of that State cannot be taken into account for the determination of the market referred to”
And at paragraph 71:
“The tobacco products for oral use which are the subject of the prohibition laid down in Article 8a of Directive 89/622/EEC and repeated in Article 8 of Directive 2001/37 were new to the markets of the Member States referred to in that measure.”
“That particular situation thus authorised a difference in treatment, and it cannot validly be argued that there was a breach of the principle of non-discrimination.”
The ban rests on snus being new to the market. Sweden, where it has been sold for roughly two centuries, is excluded from the calculation of what the market is. So the product is new, and the exception is justified, and the exception is what makes the product new. I would not call that bad law — the Court had an accession treaty in front of it and had to give it effect — but anyone who expects the asymmetry to rest on evidence rather than on the sequence in which two instruments were signed will be disappointed.
The 2014 directive was challenged in turn, and on 22 November 2018 the Court decided Case C-151/17, brought by Swedish Match with the New Nicotine Alliance intervening. Consideration of the question “has disclosed nothing capable of affecting the validity” of Articles 1(c) and 17. What makes this judgment interesting is the comparison with e-cigarettes and novel products. The Court held that “electronic cigarettes are not in the same situation as tobacco products”, so treating the two categories differently does not infringe equal treatment. Then, on novel tobacco products — the category defined as anything placed on the market after 19 May 2014 that is not one of the listed types — it reasoned that their effects “could not, by definition, be observed or studied at the time when Directive 2014/40 was adopted, whereas the effects of tobacco products for oral use were, at that time, sufficiently identified and substantiated scientifically.”
Set that beside the same judgment’s statement of the precautionary principle, which justifies restrictive measures precisely where “it proves to be impossible to determine with certainty the existence or extent of the alleged risk”. Novel products get the lighter regime because less is known about them; snus keeps the ban because more is known about it. Both propositions sit in one judgment, applied to different products. The tension is real, and you can state it from the Court’s own sentences without adding anything.
Where snus stands outside the EU
The EU rule is not a world rule, and the non-EU picture is more varied than “Europe bans snus” suggests.
| Jurisdiction | Snus (tobacco) | Tobacco-free nicotine pouches | Instrument |
|---|---|---|---|
| EU, 26 member states | Prohibited | Outside the directive | Directive 2014/40/EU, Art. 17 |
| Sweden | Legal | Legal, separately regulated | Act of Accession, Annex XV Ch. X; lag (2018:2088); lag (2022:1257) |
| United Kingdom | Prohibited | Not caught by the oral-tobacco ban | TRPR 2016, reg. 17 |
| Norway | Legal | Require Directorate of Health approval before import or sale | Tobakksskadeloven § 34 d |
| Switzerland | Legal since 2019 | Regulated as tobacco-equivalent products | BAG information letter, 11 June 2019 |
The UK version is even blunter than the EU’s. Regulation 17 of the Tobacco and Related Products Regulations 2016 reads, in its entirety: “No person may produce or supply tobacco for oral use.” Britain kept the ban after leaving the EU and did not extend it to pouches.
Norway is usually described as having “banned pouches”, which is not quite right and the precise version is more useful. Snus is lawful there. What § 34 d of the tobakksskadeloven says is: “Det er forbudt å føre inn i Norge eller selge nye tobakks- eller nikotinprodukter uten at produktet er godkjent av Helsedirektoratet.” It is prohibited to import into Norway or sell new tobacco or nicotine products unless the product has been approved by the Directorate of Health. That is prohibition by non-approval, not a named ban — a distinction that matters if you want to understand why the position could change without any new legislation. Our Norway guide and Germany guide go through each market in detail.
Switzerland reversed its own oral-tobacco ban. A Federal Office of Public Health information letter of 11 June 2019 states that “Tabakerzeugnisse zum oralen Gebrauch dürfen ab sofort in der Schweiz wie andere Tabakerzeugnisse eingeführt und abgegeben werden”, following a Federal Supreme Court decision of 27 May 2019 (2C_718/2018).
Why nicotine pouches are legal in countries where snus is not
This is the part that confuses people in shops, and the explanation is entirely definitional.
Article 17 prohibits tobacco for oral use. Article 2(8) requires the product to be “made wholly or partly of tobacco”. Article 2(4) defines tobacco products as those that “consist, even partly, of tobacco, whether genetically modified or not”. A pouch containing nicotine, cellulose, flavouring and a pH adjuster but no tobacco leaf satisfies none of those tests. It is not a tobacco product, so the article cannot reach it.
That is not a reading I am offering — the Commission has said it outright. Answering parliamentary question E-002498/2023 on 25 October 2023, Commissioner Kyriakides stated that “tobacco-free nicotine pouches are currently outside the scope of the Tobacco Products Directive 2014/40/EU (TPD)”.
The UK’s Committee on Toxicity reached the same place in its March 2022 discussion paper: “Oral nicotine pouches are tobacco-free products, hence they fall outside the Tobacco and Related Products Regulations (TRPR, 2016).” It added, and this is the sharpest statement of the gap I have seen from an official body, that “the regulatory position on them currently is likely to be under the General Product Safety Regulations (GPSR) (2005)” — a regime which, in COT’s own words, generally requires “less stringent toxicological data to be provided.”
So the practical outcome in Germany or France is this: a tin of tobacco-leaf snus is prohibited, and a tin of tobacco-free pouches delivering a comparable or larger dose of the same drug falls outside the instrument entirely, to be caught or not caught by whatever national rules exist. Several member states have since legislated their own answers, which is why the map is now a patchwork rather than a single rule; our regulation tracker keeps that current. Globally, Duren and colleagues surveyed 67 countries and found that “34 countries regulate nicotine pouches with 23 of these countries’ policies encompassing synthetic nicotine”, and of those 34, “16 regulate pouches as a tobacco product”. That work was funded by Bloomberg Philanthropies’ Bloomberg Initiative to Reduce Tobacco Use, with a CDC/NIOSH training grant for one author, and declares “Competing interests None declared” — a tobacco-control-aligned funder rather than a commercial one, which is worth knowing either way.
What Sweden actually looks like under its exemption
Three things about the Swedish market complicate the tidy version of this story in which Sweden simply got it right.
Use is rising, fastest among the group the 1992 directive named. Folkhälsomyndigheten’s national public health survey, reporting 2024 data on a page last updated 10 June 2026, records that “År 2024 uppgav 22 procent av männen och 10 procent av kvinnorna i åldern 16–84 år att de snusar varje dag” — 22% of men and 10% of women aged 16–84 using snus daily. The agency notes that “under de senaste åren har användningen av snus ökat, efter att länge ha varit relativt oförändrad”. And among women aged 16–29: “Där har andelen som snusar dagligen ökat från 3 procent år 2018 till 18 procent år 2024.” Three per cent to eighteen in six years, in the demographic the directive was written to protect. (Sweden’s other national survey, run by CAN, puts daily male use lower, at 16% for the same year. Different instrument, different age frame. I would name whichever survey you are quoting rather than averaging them.)
The labelling rules are inverted between the two product classes. Article 13(1)(a) of the directive provides that tobacco labels “shall not include any information about the nicotine, tar or carbon monoxide content of the tobacco product”, and Sweden transposed that faithfully: a tin of snus may not print its nicotine content. Meanwhile Sweden’s separate regime for tobacco-free nicotine products, under lag (2022:1257) and its implementing ordinance, requires the package to carry an ingredient list in descending order of weight, a statement of the nicotine in the product and its distribution per dose, a keep-out-of-reach-of-children recommendation, and the warning “Denna produkt innehåller nikotin som är ett mycket beroendeframkallande ämne.” One Swedish shelf therefore holds a tin forbidden to state its nicotine content beside a tin required to state it per portion. Both are 18+: lag (2018:2088) for tobacco, lag (2022:1257) for the tobacco-free products.
And the tax treats snus as its own category. Skatteverket’s rates, applying from 1 January 2026, set snus at “435 kronor per kilo” against “2 525 kronor per kilo” for other tobacco. Roughly a sixth, per kilo, for the product the rest of the Union prohibits.
What the EU’s own scientists actually concluded
One sentence from this literature circulates more than any other, and it is almost always quoted without its surroundings. It comes from the SCENIHR opinion on the health effects of smokeless tobacco products, adopted 6 February 2008:
“It is undeniable that for an individual substitution of tobacco smoking by the use of moist snuff would decrease the incidence of tobacco related diseases.”
That is the EU’s own scientific committee, and it is a real sentence. It is also about an individual, about substitution for smoking, and about relative incidence — and the same document says all of the following:
“STP are carcinogenic to humans and the pancreas has been identified as a main target organ.”
“All STP cause localised oral lesions and a high risk for development of oral cancer has been shown for various STP but the evidence for oral cancer in users of Swedish moist snuff (snus) is less clear.”
“There is evidence for an increased risk of fatal myocardial infarction among STP users.”
“STP are addictive and their use is hazardous to health.”
The committee also found it was not possible “to draw conclusions as to the relative effectiveness of smokeless tobacco as an aid to smoking cessation in comparison with established therapies”. Nothing here says snus is safe, and nobody should write that it does. What it says is that if a given smoker completely replaces cigarettes with moist snuff, their risk of smoking-related disease falls — alongside a flat statement that the product is addictive and hazardous in its own right.
One date is worth holding onto: 2008. When the Commission was asked about smokeless tobacco policy in 2021, it was still relying on that opinion, restating that it “confirmed the negative health effects of all smokeless tobacco products” and that smokeless tobacco “can cause cancer, increases the risk of death after myocardial infarction and is addictive”. The EU’s standing scientific assessment of oral tobacco predates both the directive that currently bans it and the entire nicotine pouch category.
Frequently asked questions
Can I legally bring snus into an EU country for my own use?
The directive binds member states to prohibit “placing on the market”, which is a commercial act. Whether personal importation, possession and use are separately caught is a question of national law, and it differs country by country — several member states reach the importer or the distance seller, some do not reach the consumer at all. Do not take the answer for one country from a page about another. Each market’s own rules are set out in our global map.
Why can I buy American chewing tobacco in the EU but not snus?
Because Article 2(8) excludes products “intended to be inhaled or chewed” from the definition of tobacco for oral use. The exclusion turns on intended use, not on composition or risk.
Does the ban apply to tobacco-free pouches?
No. The Commission has stated that they are “currently outside the scope” of the directive. Individual member states have legislated their own rules, and several have banned or restricted them nationally — but not under Article 17.
Could the EU lift the snus ban?
It would take new legislation; the Court has upheld the current rule as recently as 2018 and has repeatedly said the legislature enjoys “a broad discretion” here, with a measure falling only if “manifestly inappropriate”. The Commission has indicated that emerging nicotine products are within the scope of its ongoing evaluation of the tobacco framework, which is the realistic place to watch.
Is Sweden allowed to export snus to other EU countries?
No, and this is stronger than a simple prohibition on the buyer’s side. Annex XV of the Act of Accession obliges Sweden to “take all measures necessary” to ensure the product is not placed on the market in states where the directives apply in full.
Sources
- Directive 2014/40/EU of 3 April 2014, OJ L 127/1, 29.4.2014 — Articles 1, 2(4), 2(8), 13(1)(a), 17; recitals 20 and 32.
- Council Directive 92/41/EEC of 15 May 1992, OJ No L 158/30, 11 June 1992 — new Articles 2(4) and 8a, and the recitals on youth uptake.
- Court of Justice, Case C-210/03 Swedish Match, judgment of 14 December 2004 — paragraphs 11, 67, 71.
- Court of Justice, Case C-434/02 Arnold André, judgment of 14 December 2004.
- Court of Justice, Case C-151/17 Swedish Match and New Nicotine Alliance, judgment of 22 November 2018.
- European Commission, answer to parliamentary question E-002498/2023, 25 October 2023.
- SCENIHR, Opinion on Health Effects of Smokeless Tobacco Products, adopted 6 February 2008.
- Committee on Toxicity, TOX/2022/22, Nicotine pouches (updated), March 2022.
- The Tobacco and Related Products Regulations 2016, SI 2016/507, regulation 17.
- Lov om vern mot tobakksskader (tobakksskadeloven), §§ 2, 17 and 34 d. Read from the official statute PDF hosted by Arbeidstilsynet, because Lovdata was not reachable.
- Bundesamt für Gesundheit, Informationsschreiben Snus, 11 June 2019, citing Bundesgericht 2C_718/2018 of 27 May 2019.
- Lag (2018:2088) om tobak och liknande produkter, and lag (2022:1257) om tobaksfria nikotinprodukter with förordning (2022:1263).
- Folkhälsomyndigheten, Snusning i Sverige, page updated 10 June 2026, reporting 2024 survey data.
- Skatteverket, Skattesatser för tobak, page updated 27 November 2025, rates from 1 January 2026.
- Duren M, Atella L, Welding K, Kennedy RD. “Nicotine pouches: a summary of regulatory approaches across 67 countries.” Tobacco Control 2024;33:e32–e40. Author manuscript, CDC Stacks. Funded by Bloomberg Philanthropies’ Bloomberg Initiative to Reduce Tobacco Use; competing interests “None declared”.
I could not open the 1994 Act of Accession itself on EUR-Lex; Annex XV, Chapter X is quoted here as the Court of Justice reproduced it in Case C-210/03, which is why that judgment rather than the treaty is cited for the derogation’s wording. Last verified 4 October 2026.
If you want the product rather than the law, start with what snus actually is, then white portion versus original portion and how it is made. For the tobacco-free side of the shelf, pouches explained is the place to start, and the master ranking covers what is worth buying.